American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
ContributorsCuker, Adam ; Tseng, Eric K ; Schünemann, Holger J ; Angchaisuksiri, Pantep; Blair, Clifton; Dane, Kathryn; DeSancho, Maria T; Diuguid, David; Griffin, Daniel O ; Kahn, Susan R ; Klok, Frederikus A ; Lee, Alfred Ian ; Neumann, Ignacio; Pai, Ashok; Righini, Marc Philip; Sanfilippo, Kristen M ; Siegal, Deborah M ; Skara, Mike; Terrell, Deirdra R ; Touri, Kamshad; Akl, Elie A ; Al Jabiri, Reyad; Al Jabiri, Yazan; Boulos, Mary ; Brignardello-Petersen, Romina ; Charide, Rana ; Colunga-Lozano, Luis E ; Dearness, Karin ; Darzi, Andrea J ; Karam, Samer G ; Morgano, Gian Paolo ; Morsi, Rami Z ; Philip, Binu A; Benitez, Yetiani Roldan; Stevens, Adrienne ; Solo, Karla ; Wiercioch, Wojtek ; Mustafa, Reem A ; Nieuwlaat, Robby
Published inBlood advances, vol. 6, no. 17, p. 4975-4982
Publication date2022-09-13
First online date2022-06-24
Abstract
Keywords
- Anticoagulants / therapeutic use
- COVID-19
- Critical Illness / therapy
- Hematology
- Humans
- United States
- Venous Thromboembolism / drug therapy
- Venous Thromboembolism / etiology
- Venous Thromboembolism / prevention & control
Affiliation entities
Research groups
Funding
- NHLBI NIH HHS - [K01 HL135466]
Citation (ISO format)
CUKER, Adam et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. In: Blood advances, 2022, vol. 6, n° 17, p. 4975–4982. doi: 10.1182/bloodadvances.2022007940
Main files (1)
Article (Published version)
Identifiers
- PID : unige:167115
- DOI : 10.1182/bloodadvances.2022007940
- PMID : 35748885
- PMCID : PMC9236618
ISSN of the journal2473-9529